KFDA to review 855 of new drugs in few years.

Published: 2004-09-21 06:58:00

Updated: 2004-09-21 06:58:00

At present the total 855 drugs should be reviewed, of which the products from GSK among the foreign multinational drug corporations and Dong-A among the domestic drug firms are predominant. Lipitor, Plavix and Aprobel will be completed its review soon.

The drug review system is to re-evaluate its efficacy and safety especially for the new drug, and the KFDA statistics showed the total 855 ne...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.